|
IlosoneDrug - Ilosone The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Erythromycin Estolate
Strength -
EQ 250MG BASE/5ML
Applicant -
LILLY
New Drug Application (NDA) Number -
050010
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Lilly Research Laboratories Div Eli Lilly And Co
Ilosone
Ilosone Eq 250mg Base/5ml Suspension; Oral
Ilosone Eq 125mg Base/5ml For Suspension; Oral Ilosone Eq 100mg Base/ml Suspension/drops; Oral Erythromycin Estolate Eq 125mg Base/5ml Suspension; Oral Erythromycin Estolate Eq 250mg Base/5ml Suspension; Oral Erythromycin Estolate Eq 125mg Base/5ml Suspension; Oral Erythromycin Estolate Eq 250mg Base/5ml Suspension; Oral Erythromycin Estolate Eq 250mg Base/5ml Suspension; Oral Ilosone Eq 125mg Base/5ml Suspension; Oral Ilosone Eq 125mg Base/5ml Suspension; Oral NewDrugInformation |